Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - ALBIREO PHARMA, INC. | y88343e10vk.htm |
| EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | y88343exv23w1.htm |
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | y88343exv21w1.htm |
| EX-31.02 - EX-31.02 - ALBIREO PHARMA, INC. | y88343exv31w02.htm |
| EX-31.01 - EX-31.01 - ALBIREO PHARMA, INC. | y88343exv31w01.htm |
| EX-10.23 - EX-10.23 - ALBIREO PHARMA, INC. | y88343exv10w23.htm |
| EX-10.24 - EX-10.24 - ALBIREO PHARMA, INC. | y88343exv10w24.htm |
Exhibit 32.01
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on
Form 10-K
of Biodel Inc. (the ‘‘Company”) for the
year ended September 30, 2010 as filed with the Securities
and Exchange Commission on the date hereof (the
“Report”), the undersigned Errol De Souza,
President and Chief Executive Officer of the Company and Gerard
Michel, Chief Financial Officer, Vice President Corporate
Development and Treasurer of the Company, each hereby certifies
that: (1) the Report fully complies with the requirements
of section 13(a) or 15(d) of the Securities Exchange Act of
1934, as amended; and (2) the information contained in the
Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.
/s/ Errol
De Souza
Errol De Souza,
President and
Chief Executive Officer
Dated: December 14, 2010
/s/ Gerard
Michel
Gerard Michel
Chief Financial Officer,
Vice President, Corporate
Development and Treasurer
Date: December 14, 2010